Di Allovate therapeutics

Circa la società

Allovate, LLC is a specialty biopharmaceutical company that is developing an improved approach to allergen-specific immunotherapy for the treatment of allergic diseases. Allergic diseases affect more than 25% of the global industrial population, at an annual cost in excess of $33 billion in the US alone. There is an enormous and growing unmet need for allergic disease modifying treatment options. Allovate’s mission is to expand the use of immunotherapy among the millions of global allergy sufferers by developing products that are safer, more effective, and easier to administer.